Microenvironmental network of clonal CXCL13+CD4+ T cells and Tregs in pemphigus chronic blisters
BACKGROUND Pemphigus, a rare autoimmune bullous disease mediated by antidesmoglein autoantibodies, can be controlled with systemic medication like rituximab and high-dose systemic corticosteroids combined with immunosuppressants. However, some patients continue to experience chronically recurrent bl...
Uloženo v:
| Hlavní autoři: | , , , , , , , , , , , , , , , , , , , , |
|---|---|
| Médium: | Artigo |
| Jazyk: | Inglês |
| Vydáno: |
American Society for Clinical Investigation
2023-12-01
|
| Edice: | The Journal of Clinical Investigation |
| Témata: | |
| On-line přístup: | https://doi.org/10.1172/JCI166357 |
| Tagy: |
Žádné tagy, Buďte první, kdo vytvoří štítek k tomuto záznamu!
|
